Gossamer Bio Inc’s recently made public that its Director Milligan Sandra acquired Company’s shares for reported $50016.0 on Aug 19 ’25. In the deal valued at $1.92 per share,26,050 shares were bought. As a result of this transaction, Milligan Sandra now holds 58,050 shares worth roughly $0.15 million.
Scotiabank initiated its Gossamer Bio Inc [GOSS] rating to a Sector outperform in a research note published on July 14, 2025; the price target was $11. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who began to cover the stock in late June with a ‘”an Outperform”‘ rating. UBS revised its rating on July 27, 2023. It rated GOSS as “a Neutral” which previously was an “a Buy”.
Price Performance Review of GOSS
On Tuesday, Gossamer Bio Inc [NASDAQ:GOSS] saw its stock jump 7.20% to $2.53. Over the last five days, the stock has gained 31.77%. Gossamer Bio Inc shares have risen nearly 183.92% since the year began. Nevertheless, the stocks have risen 179.68% over the past one year. While a 52-week high of $2.44 was reached on 08/26/25, a 52-week low of $0.66 was recorded on 04/09/25.
Levels Of Support And Resistance For GOSS Stock
The 24-hour chart illustrates a support level at 2.41, which if violated will result in even more drops to 2.30. On the upside, there is a resistance level at 2.61. A further resistance level may holdings at 2.69.
How much short interest is there in Gossamer Bio Inc?
A steep rise in short interest was recorded in Gossamer Bio Inc stocks on 2025-07-31, growing by 1.84 million shares to a total of 18.75 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 16.91 million shares. There was a rise of 9.81%, which implies that there is a positive sentiment for the stock.
